Skip to content

A cascade-amplified Fe3O4-based nanoplatform for miRNA-21 sensing and combined apoptosis/ferroptosis induction

Aug 2026 · Microchimica Acta · Vol 193 · 0 citations · 41 references
Medicine

TL;DR

A targeted multifunctional nanotherapeutic platform by integrating ferroptosis induction, gene modulation, and chemotherapeutic intervention with highly sensitive and selective miRNA-21 sensing capability is established, laying the groundwork for precision tumor therapy.

View source

Similar papers

Sep 2026

Autophagy-mediated amplification of ferroptosis via a curcumin-loaded metal-enzyme nanoplatform for synergistic tumor therapy.

Ferroptosis is an iron-mediated cell death process driven by lipid peroxidation, yet its antitumor potential is often counteracted by the limited endogenous H2O2 content, the strict catalytic conditions required for the Fenton reaction, and protective autophagy. Notably, sustained autophagy drives ferritin degradation...

Chen-Shuo Wang, Zhen-Zhen Ma, Meng-Yu Liu et al. · 0 citations
Aug 2026

Biotin-Conjugated Polypyrrole-Coated Graphene Oxide Nanoplatform for Tumor-Targeted IR820 Delivery and Chemophotothermal Therapeutic Benefit in Cancer

The developed carbon-based nanoplatform showed significant tumor specificity and inhibition, making it a significant approach for a potential multifunctional treatment strategy for cancer.

Z. Sarkar, Varshini Are, Bhavesha Chanchlani et al. · 0 citations
Open access Aug 2026

Cerium molybdate-doped polyaniline nanoplatform for GSH-depletion-enhanced chemodynamic/NIR-II photothermal synergistic therapy via ferroptosis and immune activation

Cerium molybdate-doped polyaniline nanoparticles are developed to enable a synergistic combination of photothermal therapy (PTT) and CDT, thereby triggering immunogenic cell death (ICD) and enhancing antitumor immunity and presenting a robust nanoplatform integrating chemodynamic and photothermal therapies for potent c...

Yulin Kuang, Cheng Lu, Bo-Lan Yu et al. · 0 citations
Sep 2026

A mitochondria-targeted supramolecular nanoplatform overcomes cisplatin resistance via self-amplified ferroptosis.

An upregulated GPX4 level of tumor cells with enhanced antioxidant defense systems accounts substantially for cisplatin resistance, but on the other hand, offers a unique therapeutic strategy due to the improved sensitivity of tumor cells to ferroptosis. Effective ferroptosis induction remains a challenge owing to insu...

Ying Liu, Zong-Tao Zhou, Wei Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.